Following the discovery of PD-1 and its ligand PD-L1 by Tasuku Honjo and Lieping Chen, respectively, it was shown (by Lieping Chen) that PD-L1 was upregulated in several cancers and blocking of the PD-L1/PD-1 interactions lead to tumour regression in mice [20]. Here, CD274 is linked to neoplasm.